Ryan Ayers

Ryan Ayers is an Executive Oncology Specialist at Amgen, where they successfully launched the first KRASG12C oral oncolytic for NSCLC. Previously, Ryan held the position of Executive Biopharmaceutical Representative at Amgen, achieving recognition with three Chairman’s circle awards for the launch of a PCSK9 inhibitor. With extensive experience as an Executive Sales Representative at Novartis, Ryan excelled in promoting leading anti-hypertensive medications, earning multiple awards throughout their tenure. Ryan began their professional journey as a Program Manager at Visa, where they provided strategic counsel that yielded significant operational savings. They hold a Master's degree in Business Administration from the University of Phoenix and a Bachelor of Science in Ecology and Evolutionary Biology from the University of Arizona.